Yahoo Web Search

Search results

1. • ... Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic...

     The Pilot News· 20 hours ago

     Food and Drug Administration (FDA) for clinical trials of 225Ac-FL-020, its PSMA-targeted radiopharmaceutical for the treatment of metastatic castration-resistant prostate ...

2. • 

     Top 10 most common cancers among Blacks

     Rolling Out· 1 day ago

     Understanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.

3. • 

     Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why

     Zacks via Yahoo Finance· 2 days ago

     Candel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...

4. • 

     Why I Told the World I Was Living With Cancer

     Level Man via Yahoo News· 4 days ago

     On April 5 of 2023 , I received life-altering news, some of which I am still processing. I was diagnosed with stage 1 prostate cancer. It was caught very...

5. • 

     Exelixis (EXEL) Down 6.6% Since Last Earnings Report: Can It Rebound?

     Zacks via Yahoo Finance· 5 hours ago

     A filing for...TKI), is being evaluated in three ongoing pivotal trials, STELLAR-303, -304 and -305,...

6. • 

     ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results

     FierceBiotech· 6 days ago

     JNJ-6420 is an anti-hK2 antibody-based targeted radioligand therapy that's designed to deliver a...

7. • AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024

     Morningstar· 2 days ago

     Data From Newly FDA-Approved IMDELLTRA™ (tarlatamab-dlle) Further Reinforce Leadership in Bispecific T-Cell Engagers Overall Survival Data from Phase 3 LUMAKRAS® (sotorasib ...

8. • ASCO: Large precision oncology study identifies di | Newswise

     Newswise· 7 days ago

     A new study led by a UCLA-VA collaborative team looking at the landscape of genomic alterations in more than 5,000 veterans with metastatic prostate cancer

9. • Cancer can be caused by reversible molecular changes – as new study shows

     The Conversation· 2 days ago

     This theory posits that DNA mutations are the primary cause of cancers. It’s well known that ageing, as well as some lifestyle and environmental factors (such as smoking and ...

10. • Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...

      WTRF Wheeling· 7 days ago

      Clinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions and present their latest discoveries from their innovative cancer ...